![Preston Noon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Preston Noon
Directeur/Bestuurslid bij ViTToria Biotherapeutics, Inc.
Actieve functies van Preston Noon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Agent Capital LLC
![]() Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Private Equity Investor | - | - |
ViTToria Biotherapeutics, Inc.
![]() ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Directeur/Bestuurslid | - | - |
Loopbaan van Preston Noon
Opleiding van Preston Noon
University of Connecticut | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Private Equity Investor | 1 |
Masters Business Admin | 1 |
Director/Board Member | 1 |
Sectoraal
Finance | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Agent Capital LLC
![]() Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Finance |
ViTToria Biotherapeutics, Inc.
![]() ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Preston Noon
- Ervaring